pharmaceuticals
Bayer tests drug cure for double chins
German pharmaceutical giant Bayer announced on Monday it was developing a drug to combat the dreaded double chin that it says could generate €250 million a year in sales.
German pharmaceutical giant Bayer announced on Monday it was developing a drug to combat the dreaded double chin that it says could generate €250 million a year in sales.